Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study

被引:5
|
作者
Merali, Nabeel [1 ,2 ,3 ]
Chouari, Tarak [2 ,3 ]
Terroire, Julien [4 ,5 ]
Jessel, Maria-Danae [3 ]
Liu, Daniel S. K. [6 ]
Smith, James-Halle [7 ]
Wooldridge, Tyler [3 ]
Dhillon, Tony [3 ]
Jimenez, Jose I. [8 ]
Krell, Jonathan [6 ]
Roberts, Keith J. [7 ]
Rockall, Timothy A. [1 ]
Velliou, Eirini [9 ]
Sivakumar, Shivan [10 ]
Giovannetti, Elisa [11 ,12 ]
Demirkan, Ayse [4 ,5 ]
Annels, Nicola E. [3 ]
Frampton, Adam E. [1 ,2 ,3 ,6 ]
机构
[1] Royal Surrey Cty Hosp NHS Fdn Trust, Minimal Access Therapy & Training Unit MATTU, Leggett Bldg, Guildford GU2 7XX, England
[2] Royal Surrey Cty Hosp NHS Fdn Trust, Dept Hepatopancreato Biliary HPB Surg, Guildford GU2 7XX, England
[3] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Sect Oncol, Guildford GU2 7WG, England
[4] Univ Surrey, Surrey Inst People Centred AI, Guildford GU2 7XH, England
[5] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Sect Stat Multi, Guildford GU2 7WG, England
[6] Imperial Coll London, Div Canc, Dept Surg & Canc, Hammersmith Hosp Campus, London W12 0NN, England
[7] Univ Birmingham, Queen Elizabeth Hosp Birmingham, Coll Med & Dent Sci, Hepatobiliary & Pancreat Surg Unit, Birmingham B15 2TH, England
[8] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England
[9] Univ Coll London UCL, Ctr 3D Models Hlth & Dis, Dept Targeted Intervent, Div Surg & Intervent Sci, London W1W 7TY, England
[10] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham Med Sch, Oncol Dept, Birmingham B15 2TT, England
[11] VU Univ Med Ctr Canc Ctr Amsterdam, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands
[12] Fdn Pisana Sci, AIRC Start Unit, Canc Pharmacol Lab, San Giuliano Terme PI, I-56017 Pisa, Italy
关键词
pancreatic cancer; microbiome; 16S rRNA gene; bile; biomarker; TUMOR MICROBIOME; CANCER; GEMCITABINE;
D O I
10.3390/ijms242316888
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) has a very poor survival. The intra-tumoural microbiome can influence pancreatic tumourigenesis and chemoresistance and, therefore, patient survival. The role played by bile microbiota in PDAC is unknown. We aimed to define bile microbiome signatures that can effectively distinguish malignant from benign tumours in patients presenting with obstructive jaundice caused by benign and malignant pancreaticobiliary disease. Prospective bile samples were obtained from 31 patients who underwent either Endoscopic Retrograde Cholangiopancreatography (ERCP) or Percutaneous Transhepatic Cholangiogram (PTC). Variable regions (V3-V4) of the 16S rRNA genes of microorganisms present in the samples were amplified by Polymerase Chain Reaction (PCR) and sequenced. The cohort consisted of 12 PDAC, 10 choledocholithiasis, seven gallstone pancreatitis and two primary sclerosing cholangitis patients. Using the 16S rRNA method, we identified a total of 135 genera from 29 individuals (12 PDAC and 17 benign). The bile microbial beta diversity significantly differed between patients with PDAC vs. benign disease (Permanova p = 0.0173). The separation of PDAC from benign samples is clearly seen through unsupervised clustering of Aitchison distance. We found three genera to be of significantly lower abundance among PDAC samples vs. benign, adjusting for false discovery rate (FDR). These were Escherichia (FDR = 0.002) and two unclassified genera, one from Proteobacteria (FDR = 0.002) and one from Enterobacteriaceae (FDR = 0.011). In the same samples, the genus Streptococcus (FDR = 0.033) was found to be of increased abundance in the PDAC group. We show that patients with obstructive jaundice caused by PDAC have an altered microbiome composition in the bile compared to those with benign disease. These bile-based microbes could be developed into potential diagnostic and prognostic biomarkers for PDAC and warrant further investigation.
引用
收藏
页数:13
相关论文
共 46 条
  • [31] A pilot study of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice
    Yang, MinJie
    Yan, ZhiPing
    Luo, JianJun
    Liu, QingXin
    Zhang, Wen
    Ma, JinQing
    Zhang, ZiHan
    Yu, TianZhu
    Zhao, Qian
    Liu, LingXiao
    BRACHYTHERAPY, 2016, 15 (06) : 859 - 866
  • [32] Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: can we predict survival using perfusion parameters? A pilot study
    Constantin, Alina L.
    Cazacu, Irina M.
    Burtea, Daniela Elena
    Harbiyeli, Irina F. Cherciu
    Bejinariu, Nona
    Popescu, Carmen F.
    Serbanescu, Mircea S.
    Tabacelia, Daniela
    Copaescu, Catalin
    Bhutani, Manoop S.
    Stroescu, Cezar
    Saftoiu, Adrian
    MEDICAL ULTRASONOGRAPHY, 2022, 24 (04) : 393 - 398
  • [33] Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma
    Nishimura, Toshihide
    Takadate, Tatsuyuki
    Maeda, Shimpei
    Suzuki, Takashi
    Minowa, Takashi
    Fukuda, Tetsuya
    Bando, Yasuhiko
    Unno, Michiaki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma
    Basile Tessier-Cloutier
    Steve E. Kalloger
    Mohammad Al-Kandari
    Katy Milne
    Dongxia Gao
    Brad H. Nelson
    Daniel J. Renouf
    Brandon S. Sheffield
    David F. Schaeffer
    BMC Cancer, 17
  • [35] Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
    Dong, Qian
    Yang, Xiang-hong
    Zhang, Yao
    Jing, Wei
    Zheng, Li-qiang
    Liu, Yun-peng
    Qu, Xiu-juan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [36] CD44+Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study
    Xing, Cheng
    Li, Yatong
    Ding, Cheng
    Wang, Shunda
    Zhang, Hanyu
    Chen, Lixin
    Li, Pengyu
    Dai, Menghua
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4417 - 4431
  • [37] Extensive (subtotal) distal pancreatectomy for pancreatic ductal adenocarcinoma: a propensity score matched cohort study of short- and long-term outcomes compared with those of conventional distal pancreatectomy
    Watanabe, Yusuke
    Nakata, Kohei
    Mori, Yasuhisa
    Ideno, Noboru
    Ikenaga, Naoki
    Ohtsuka, Takao
    Nakamura, Masafumi
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (04) : 1479 - 1488
  • [38] Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom A Pilot Study
    Kim, Harrison
    Morgan, Desiree E.
    Schexnailder, Patrick
    Navari, Rudolph M.
    Williams, Grant R.
    Rose, J. Bart
    Li, Yufeng
    Paluri, Ravikumar
    INVESTIGATIVE RADIOLOGY, 2019, 54 (01) : 16 - 22
  • [39] Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
    Argentiero, Antonella
    De Summa, Simona
    Di Fonte, Roberta
    Iacobazzi, Rosa Maria
    Porcelli, Letizia
    Da Via, Matteo
    Brunetti, Oronzo
    Azzariti, Amalia
    Silvestris, Nicola
    Solimando, Antonio Giovanni
    CANCERS, 2019, 11 (07)
  • [40] Transabdominal ultrasound of pancreatic ductal adenocarcinoma: A multi-centered population-based study in sensitivity, associated diagnostic intervals, and survival
    Kang, Jessie
    Abdolell, Mohamed
    Costa, Andreu F.
    CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2022, 51 (06) : 842 - 847